We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been promoted to Vice President, Finance and Controller...
MOUNTAIN VIEW, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that it will host an investor/analyst meeting on Thursday, February 18, 2010...
MOUNTAIN VIEW, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that the U.S. Food & Drug Administration has accepted the AZ-004 NDA for...
Conference Call Scheduled for Today -Wednesday, February 10, 2010 at 8:30 a.m. Eastern Time MOUNTAIN VIEW, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA...
MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that its corporate presentation will be webcast live during the 21st Annual...
In the news release, Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) Sets Price for Initial Public Offering, issued earlier today by Alexza Pharmaceuticals, Inc. over PR Newswire, we are advised by...
PALO ALTO, Calif., March 8 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today the initial public offering of 5,500,000 shares of common stock at a price of $8...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions